• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较 N 型(钙通道 2.2)钙通道失活状态阻断。

Comparative analysis of inactivated-state block of N-type (Ca(v)2.2) calcium channels.

机构信息

Neuroscience Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Dept R4PM, Bldg. AP9A, 100 Abbott Park Road, Abbott Park, IL 60064-6125, USA.

出版信息

Inflamm Res. 2011 Jul;60(7):683-93. doi: 10.1007/s00011-011-0322-9. Epub 2011 Mar 11.

DOI:10.1007/s00011-011-0322-9
PMID:21394563
Abstract

OBJECTIVE

The aim of this study was to compare a diverse set of peptide and small-molecule calcium channel blockers for inactivated-state block of native and recombinant N-type calcium channels using fluorescence-based and automated patch-clamp electrophysiology assays.

METHODS

The pharmacology of calcium channel blockers was determined at N-type channels in IMR-32 cells and in HEK cells overexpressing the inward rectifying K(+) channel Kir2.1. N-type channels were opened by increasing extracellular KCl. In the Kir2.1/N-type cell line the membrane potential could be modulated by adjusting the extracellular KCl, allowing determination of resting and inactivated-state block of N-type calcium channels. The potency and degree of state-dependent inhibition of these blockers were also determined by automated patch-clamp electrophysiology.

RESULTS

N-type-mediated calcium influx in IMR-32 cells was determined for a panel of blockers with IC(50) values of 0.001-7 μM and this positively correlated with inactivated-state block of recombinant channels measured using electrophysiology. The potency of several compounds was markedly weaker in the state-dependent fluorescence-based assay compared to the electrophysiology assay, although the degree of state-dependent blockade was comparable.

CONCLUSIONS

The present data demonstrate that fluorescence-based assays are suitable for assessing the ability of blockers to selectively interact with the inactivated state of the N-type channel.

摘要

目的

本研究旨在使用荧光和自动膜片钳电生理学检测比较一组不同的肽类和小分子钙通道阻滞剂对天然和重组 N 型钙通道失活状态的阻断作用。

方法

通过增加细胞外 KCl 来开放钙通道阻滞剂在 IMR-32 细胞和过表达内向整流钾通道 Kir2.1 的 HEK 细胞中的 N 型通道的药理学研究。在 Kir2.1/N 型细胞系中,通过调节细胞外 KCl 可以调节膜电位,从而确定 N 型钙通道的静息和失活状态阻断。通过自动膜片钳电生理学还确定了这些阻滞剂的效力和状态依赖性抑制程度。

结果

为一组具有 0.001-7 μM IC50 值的阻滞剂确定了 IMR-32 细胞中的 N 型介导的钙内流,并且这与使用电生理学测量的重组通道的失活状态阻断呈正相关。与电生理学测定相比,几种化合物在基于荧光的状态依赖性测定中的效力明显较弱,尽管状态依赖性阻断程度相当。

结论

目前的数据表明,荧光测定适用于评估阻滞剂选择性与 N 型通道失活状态相互作用的能力。

相似文献

1
Comparative analysis of inactivated-state block of N-type (Ca(v)2.2) calcium channels.比较 N 型(钙通道 2.2)钙通道失活状态阻断。
Inflamm Res. 2011 Jul;60(7):683-93. doi: 10.1007/s00011-011-0322-9. Epub 2011 Mar 11.
2
Characterization of the substituted N-triazole oxindole TROX-1, a small-molecule, state-dependent inhibitor of Ca(V)2 calcium channels.取代 N-三唑吲哚 TROX-1 的特性研究,一种小分子、钙通道状态依赖性 Ca(V)2 钙通道抑制剂。
Mol Pharmacol. 2012 Mar;81(3):488-97. doi: 10.1124/mol.111.075226. Epub 2011 Dec 21.
3
A fluorescence-based high-throughput screening assay for the identification of T-type calcium channel blockers.一种基于荧光的高通量筛选测定法,用于鉴定T型钙通道阻滞剂。
Assay Drug Dev Technol. 2009 Jun;7(3):266-80. doi: 10.1089/adt.2009.191.
4
Pharmacological characterization of recombinant N-type calcium channel (Cav2.2) mediated calcium mobilization using FLIPR.使用荧光成像板读数器(FLIPR)对重组N型钙通道(Cav2.2)介导的钙动员进行药理学特性分析。
Biochem Pharmacol. 2006 Sep 14;72(6):770-82. doi: 10.1016/j.bcp.2006.06.003. Epub 2006 Jul 17.
5
Generation and characterization of a cell line with inducible expression of Ca(v)3.2 (T-type) channels.具有可诱导表达Ca(v)3.2(T型)通道的细胞系的生成与特性分析
Assay Drug Dev Technol. 2003 Oct;1(5):637-45. doi: 10.1089/154065803770380995.
6
Kurtoxin, a gating modifier of neuronal high- and low-threshold ca channels.库尔毒素,一种神经元高阈值和低阈值钙通道的门控修饰剂。
J Neurosci. 2002 Mar 15;22(6):2023-34. doi: 10.1523/JNEUROSCI.22-06-02023.2002.
7
Analgesic effects of a substituted N-triazole oxindole (TROX-1), a state-dependent, voltage-gated calcium channel 2 blocker.取代的 N-三唑吲哚(TROX-1)作为一种状态依赖性、电压门控钙通道 2 阻断剂的镇痛作用。
J Pharmacol Exp Ther. 2010 Aug;334(2):545-55. doi: 10.1124/jpet.110.166363. Epub 2010 May 3.
8
Ca2+-dependent inactivation of CaV1.2 channels prevents Gd3+ block: does Ca2+ block the pore of inactivated channels?CaV1.2通道的钙依赖性失活可防止钆离子(Gd3+)阻断:钙离子是否会阻断失活通道的孔道?
J Gen Physiol. 2007 Jun;129(6):477-83. doi: 10.1085/jgp.200709734.
9
Voltage-dependent blockade of diverse types of voltage-gated Ca2+ channels expressed in Xenopus oocytes by the Ca2+ channel antagonist mibefradil (Ro 40-5967).通过钙通道拮抗剂米贝地尔(Ro 40 - 5967)对非洲爪蟾卵母细胞中表达的多种类型电压门控钙通道进行电压依赖性阻断。
Mol Pharmacol. 1995 Sep;48(3):540-9.
10
A high-throughput assay for evaluating state dependence and subtype selectivity of Cav2 calcium channel inhibitors.一种用于评估Cav2钙通道抑制剂的状态依赖性和亚型选择性的高通量检测方法。
Assay Drug Dev Technol. 2008 Apr;6(2):195-212. doi: 10.1089/adt.2008.136.

引用本文的文献

1
Optimization of ADME Properties for Sulfonamides Leading to the Discovery of a T-Type Calcium Channel Blocker, ABT-639.磺胺类药物的吸收、分布、代谢和排泄特性优化,促成T型钙通道阻滞剂ABT-639的发现。
ACS Med Chem Lett. 2015 Apr 28;6(6):641-4. doi: 10.1021/acsmedchemlett.5b00023. eCollection 2015 Jun 11.

本文引用的文献

1
Analgesic effects of a substituted N-triazole oxindole (TROX-1), a state-dependent, voltage-gated calcium channel 2 blocker.取代的 N-三唑吲哚(TROX-1)作为一种状态依赖性、电压门控钙通道 2 阻断剂的镇痛作用。
J Pharmacol Exp Ther. 2010 Aug;334(2):545-55. doi: 10.1124/jpet.110.166363. Epub 2010 May 3.
2
Structure-activity relationships of diphenylpiperazine N-type calcium channel inhibitors.二苯哌嗪 N 型钙通道抑制剂的构效关系。
Bioorg Med Chem Lett. 2010 Feb 15;20(4):1378-83. doi: 10.1016/j.bmcl.2010.01.008. Epub 2010 Jan 7.
3
Positive allosteric interaction of structurally diverse T-type calcium channel antagonists.
结构多样的T型钙通道拮抗剂的正变构相互作用
Cell Biochem Biophys. 2009;55(2):81-93. doi: 10.1007/s12013-009-9057-4. Epub 2009 Jul 7.
4
A fluorescence-based high-throughput screening assay for the identification of T-type calcium channel blockers.一种基于荧光的高通量筛选测定法,用于鉴定T型钙通道阻滞剂。
Assay Drug Dev Technol. 2009 Jun;7(3):266-80. doi: 10.1089/adt.2009.191.
5
Experimental studies of potential analgesics for the treatment of chemotherapy-evoked painful peripheral neuropathies.用于治疗化疗引起的疼痛性外周神经病变的潜在镇痛药的实验研究。
Pain Med. 2008 Jul-Aug;9(5):505-17. doi: 10.1111/j.1526-4637.2007.00301.x.
6
A high-throughput assay for evaluating state dependence and subtype selectivity of Cav2 calcium channel inhibitors.一种用于评估Cav2钙通道抑制剂的状态依赖性和亚型选择性的高通量检测方法。
Assay Drug Dev Technol. 2008 Apr;6(2):195-212. doi: 10.1089/adt.2008.136.
7
Automated electrophysiology in drug discovery.药物研发中的自动化电生理学
Curr Pharm Des. 2007;13(23):2325-37. doi: 10.2174/138161207781368701.
8
A nonadherent cell-based HTS assay for N-type calcium channel using calcium 3 dye.
Assay Drug Dev Technol. 2006 Dec;4(6):689-94. doi: 10.1089/adt.2006.4.689.
9
Pharmacological characterization of recombinant N-type calcium channel (Cav2.2) mediated calcium mobilization using FLIPR.使用荧光成像板读数器(FLIPR)对重组N型钙通道(Cav2.2)介导的钙动员进行药理学特性分析。
Biochem Pharmacol. 2006 Sep 14;72(6):770-82. doi: 10.1016/j.bcp.2006.06.003. Epub 2006 Jul 17.
10
Targeting chronic and neuropathic pain: the N-type calcium channel comes of age.靶向慢性和神经性疼痛:N型钙通道走向成熟。
NeuroRx. 2005 Oct;2(4):662-70. doi: 10.1602/neurorx.2.4.662.